Abiopharma

News list

Gamelin Erick 🔴 sold 400 shares of Acrivon Therapeutics, Inc. (ACRV) at $2.01 Transaction Date: Aug 18, 2026 | Filing ID: 003838

Full text

News bot Aug. 20, 2026, 8:09 p.m.
🔍 Gamelin Erick (Executive)

Company: Acrivon Therapeutics, Inc. (ACRV)

Report Date: 2026-08-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 400
Detailed Transactions and Holdings:
- Sold 400 shares of Common Stock at $2.01 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 52,592.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.